Dr Reddy''s launches lansoprazole capsules in US market - MSN India

New Delhi, May 21 (PTI) Drug firm Dr Reddy''s Laboratories today said it has launched its generic version of lansoprazole delayed-release capsules used for treating acidity and heartburns in the US market. The company has launched over-the-counter ...

Dr. Reddy's launches OTC Lansoprazole delayed-release capsules in the U.S. - News-Medical.Net

Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched over-the-counter (OTC) Lansoprazole delayed-release capsules in the U.S. market on May 18, 2012, following Dr. Reddy's ANDA approval by the United States Food & Drug ...

Dr. Reddy's Announces the Launch of Over-the-Counter Lansoprazole Delayed-Release Capsules - Marketwatch

HYDERABAD, India, May 21, 2012 (BUSINESS WIRE) -- Dr. Reddy's Laboratories (NYSE:RDY) announced today that it has launched over-the-counter (OTC) Lansoprazole delayed-release capsules in the U.S. market on May 18, 2012, following Dr. Reddy's ...

Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules - Yahoo Finance

ALLEGAN, Mich., May 18, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for Lansoprazole ...

Perrigo Receives FDA Approval For ANDA For Lansoprazole 15 Mg Capsules - RTT News

(RTTNews) - Perrigo Co. (PRGO: News ) announced Friday that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for Lansoprazole capsules (15 mg). Shipments of product to customers have ...

Perrigo Company unveils FDA approved heartburn drug Lansoprazole 15mg - MENAFN

May 21, 2012 (M2 EQUITYBITES via COMTEX) -- Healthcare supplier Perrigo Company PRGO reported on Monday the receipt of final approval from the US Food and Drug Administration for its abbreviated new drug application for Lansoprazole capsules (15 mg).

Research and Markets: Peptic Ulcer Therapeutics - Pipeline Assessment and Market Forecasts to 2018 - Business Wire

The peptic ulcer market is well served by Proton Pump Inhibitors (PPIs), which form the majority. PPIs include omeprazole, lansoprazole, pantoprazole, Nexium (esomeprazole) and Aciphex (rabeprazole); and histamine blockers such as ranitidine, nizatidine ...

Indian equity markets shed early gains - MSN India

However, Glenmark Pharma and J B Chemicals are trading firm. As per a leading financial daily, Indian drug maker Dr Reddy's Laboratories has launched its generic version of lansoprazole delayed-release capsules in the US market. The over-the-counter ...

Rupee weak, Sensex jumps at start: Will rally be sustained? - firstpost.com

Dr Reddy’s Laboratories said it has launched its generic version of lansoprazole delayed-release capsules used for treating acidity and heartburns in the US market. As per a petroleum ministry communication to oil retailers, IOC would get ...

US, Russia & API boost Dr Reddy's as busy year looms - MoneyControl.com

The other products continue to do well. Fexofenadine was a big contributor to both sales and profitability. Lansoprazole as well as the OTC products have turned in a smart performance in the US market. Q: The other big surprise this quarter was ...